Sanofi (SNW2) — Cash Flow Quality Index

Latest as of September 2025: 1.34x

Sanofi (SNW2) has a Cash Flow Quality Index of 1.34x as of September 2025. Operating cash flow of €3.75 Billion exceeds net income of €2.80 Billion, indicating high earnings quality where cash backs reported profits. Explore how well can Sanofi service its debt to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

1.34x
Operating CF / Net Income

Operating Cash Flow

€3.75 Billion
EUR

Net Income

€2.80 Billion
EUR

Data as of

Sep 2025
Most recent filing

Sanofi Cash Flow Quality Index (2016–2024)

Historical Cash Flow Quality Index for Sanofi across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see SNW2 cash flow conversion.

Annual Cash Flow Quality Index for Sanofi (2016–2024)

Year-by-year earnings quality comparison for Sanofi.

Year Quality Index Operating CF (EUR) Net Income YoY Change
2024 1.63x €9.08 Billion €5.56 Billion ▼ -14.0%
2023 1.90x €10.26 Billion €5.40 Billion ▲ +21.3%
2022 1.57x €10.53 Billion €6.72 Billion ▼ -7.4%
2021 1.69x €10.52 Billion €6.22 Billion ▲ +180.7%
2020 0.60x €7.42 Billion €12.31 Billion ▼ -78.1%
2019 2.75x €7.71 Billion €2.81 Billion ▲ +113.4%
2018 1.29x €5.55 Billion €4.31 Billion ▲ +46.9%
2017 0.88x €7.38 Billion €8.42 Billion ▼ -47.3%
2016 1.66x €7.84 Billion €4.71 Billion
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.